9 Prescribing anticipatory medicines for patients with COVID-19
For information about prescribing medicines at the end of life see the BNF's prescribing in palliative care.
9.1 When prescribing and supplying anticipatory medicines at the end of life:
Take into account potential waste, medicines shortages and lack of administration equipment by prescribing smaller quantities or by prescribing a different medicine, formulation or route of administration when appropriate.
If there are fewer health and care staff you may need to prescribe subcutaneous, rectal or long-acting formulations, and carers or family members may need to administer them.
9.2 Consider different routes for administering medicines if the patient is unable to take or tolerate oral medicines, such as sublingual or rectal routes, or subcutaneous injections.